个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
张倩，女，34岁，首都医科大学附属北京友谊医院副研究员、副教授、硕士生导师。
学习工作经历：在四川大学华西公共卫生学院、中国医学科学院/北京协和医学院、首都医科大学附属北京友谊医院进行科研学习及科研工作。主要从事消化道早癌及癌前疾病的病因学和流行病学研究；近5年，作为负责人主持5项国家/省部级课题；以第一/通讯作者发表相关SCI论文20篇，包括Am JGastroenterol、Liver Int等具有高影响力的SCI杂志；获得专利授权2项; 参编著作1部。
(1) 中华人民共和国科学技术部, 重点研发计划子任务, 2024YFC2417403, 术中人工智能多病灶原位识别技术研究——建立结肠多病灶数据库, 2024-12 至 2027-11, 50万元, 在研, 主持
(2) 中华人民共和国科学技术部, 重点研发计划子任务, 2022YFC3602101, 基于上皮及微环境特征变化的老年消化道疾病发生发展及精准诊疗的系统性研究——华北及东北地区消化道正常人群及3种常见消化道疾病的增龄队列及样本库建设, 2022-12 至 2025-12, 50万元, 在研, 主持
(3) 国家自然科学基金委员会, 青年科学基金项目（C类）[原青年科学基金项目], 72104150, 基于多状态模型的食管癌高危人群的可逆风险自我管理及成本效果研究, 2022-01-01 至 2024-12-31, 30万元, 资助期满, 主持
(4) 中共北京市委组织部, 青年骨干个人项目, 2018000021469G198, Hp感染与生活方式交互作用对胃癌前病变进展预测作用的队列研究, 2020-01 至 2022-12, 6万元, 结题, 主持
(5) 北京市自然科学基金, 青年项目, 7204249, SERPINE1在胃高级别上皮内瘤变中的中介效应及其预后预测的多状态模型研究, 2020-01 至 2021-12, 10万元, 结题, 主持
(1) 中华人民共和国科学技术部, 重点研发计划子任务, 2024YFC2417403, 术中人工智能多病灶原位识别技术研究——建立结肠多病灶数据库, 2024-12 至 2027-11, 50万元, 在研, 主持
(2) 中华人民共和国科学技术部, 重点研发计划子任务, 2022YFC3602101, 基于上皮及微环境特征变化的老年消化道疾病发生发展及精准诊疗的系统性研究——华北及东北地区消化道正常人群及3种常见消化道疾病的增龄队列及样本库建设, 2022-12 至 2025-12, 50万元, 在研, 主持
(3) 国家自然科学基金委员会, 青年科学基金项目（C类）[原青年科学基金项目], 72104150, 基于多状态模型的食管癌高危人群的可逆风险自我管理及成本效果研究, 2022-01-01 至 2024-12-31, 30万元, 资助期满, 主持
(4) 中共北京市委组织部, 青年骨干个人项目, 2018000021469G198, Hp感染与生活方式交互作用对胃癌前病变进展预测作用的队列研究, 2020-01 至 2022-12, 6万元, 结题, 主持
(5) 北京市自然科学基金, 青年项目, 7204249, SERPINE1在胃高级别上皮内瘤变中的中介效应及其预后预测的多状态模型研究, 2020-01 至 2021-12, 10万元, 结题, 主持
近5年一作/通讯SCI：
1.Guo R, Wang J, Min L, Dong N, Zhang L, Song R, Zhang Y, Zhang Q, Zhai H, Li P, Zhang S. Improved Adenoma Detection Rate Using a Novel Colonoscopic Distal Attachment: A Multicenter Randomized Controlled Trial. Am J Gastroenterol. 2024 Nov 1;119(11):2224-2232. doi: 10.14309/ajg.0000000000002829.
2.Sun X, Zhang Q, Wu S, Xu C, Zhang Y, Hao X, Meng Y, Jiao Y, Li H, Zhu S, Zhou Y, Liu K, Xu H, Zhu S, Zhang S. Effect of 3-Dimensional Imaging Device on Polyp and Adenoma Detection During Colonoscopy: A Randomized Controlled Trial. Am J Gastroenterol. 2023 Oct 1;118(10):1812-1820. doi: 10.14309/ajg.0000000000002396.
3.Zhang Q, Xu F, Liu S, Zhu S, Zhang S, Wu J, Wu S. Long-term risk of cardiovascular disease associated with MASLD and different cardiometabolic risk factors in IBD patients: A prospective cohort study. Liver Int. 2024 Sep;44(9):2315-2328. doi: 10.1111/liv.15999.
4.Zhang Q, Wu SS. Response to Jui-Ting Yu et al. Liver Int. 2024 Nov;44(11):3102. doi: 10.1111/liv.16073.
5.Zhang Q, Wang Y, Liu S, Zhu S, Li P, Wu S. Mortality risk associated with MASLD, MASLD type and different cardiometabolic risk factors in IBD patients: A long-term prospective cohort study. Dig Liver Dis. 2025 Mar;57(3):744-752. doi: 10.1016/j.dld.2024.11.002.
6. Zhang Q, Wu S. Author's reply: "Inflammatory bowel disease, MASLD, and cardiometabolic risks: Unveiling a new perspective on mortality risk". Dig Liver Dis. 2025 Mar;57(3):802-803. doi: 10.1016/j.dld.2025.01.178.
7. Zhang Q, Xu F, Wang Z, Liu S, Zhu S, Zhang S, Wu S. Long-Term Risk of Inflammatory Bowel Disease With MASLD: A Large-Scale Prospective Cohort Study in UK Biobank. J Gastroenterol Hepatol. 2025 Jan 19. doi: 10.1111/jgh.16880.
8.Zhang Q, Wang F, Feng H, Xing J, Zhu S, Zhang H, Li Y, Wei W, Zhang S. Modifiable risk factors for esophageal cancer in endoscopic screening population: A modeling study. Chin Med J (Engl). 2024 Feb 5;137(3):350-352. doi: 10.1097/CM9.0000000000002878.
9.Zhang Q, Liu S, Wu J, Zhu S, Wu Y, Wu S, Zhang S. Non-alcoholic fatty liver degree and long-term risk of incident inflammatory bowel disease: A large-scale prospective cohort study. Chin Med J (Engl). 2024 Jul 20;137(14):1705-1714. doi: 10.1097/CM9.0000000000002859.
10.Ma J, Ma X, Xing J, Song R, Zhang Y, Liu M, Guo S, Zhang Q, Wu J. Clinical and pathological characteristics of and predictive model for colorectal neuroendocrine tumors. Heliyon. 2024 Aug 2;10(15):e35720. doi: 10.1016/j.heliyon.2024.e35720.
11. Liu H, Zhang Q, Zhang S, Zhang Y, Song R, Li P, Xing J. Clinical features and risk of multiple primary malignancies after endoscopic treatment in patients with early esophageal squamous cell carcinoma: a retrospective cohort study. J Gastrointest Oncol. 2024 Aug 31;15(4):1386-1398. doi: 10.21037/jgo-24-299.
12. Li X, Zhang Q, Li W, Wei J, Xing J, Yang X, Li P, Zhang S. Clinical characteristics, depression, anxiety, and stress of medical workers during the COVID-19 pandemic: a cross-sectional survey. J Infect Dev Ctries. 2024 Sep 30;18(9):1364-1372. doi: 10.3855/jidc.19360.
13.Zhang Q, Liu S, Yuan C, Sun F, Zhu S, Guo S, Wu S, Zhang S. Frailty and pre-frailty with long-term risk of elderly-onset inflammatory bowel disease: A large-scale prospective cohort study. Ann Epidemiol. 2023 Dec;88:30-36. doi: 10.1016/j.annepidem.2023.10.006.
14.Li X, Xing J, Li P, Xie S, Lin Q, Zhang Q, Zhang S. A nomogram and risk classification system predicting esophageal stricture after endoscopic submucosal dissection of a large area for early esophageal cancer. J Surg Oncol. 2023 Mar;127(4):568-577. doi: 10.1002/jso.27172.
15.Tong Y, Zhang Q, Wang X, Du Y, Chang D, Cui Y, Duan X. Dynamic changes in mental health status related to the COVID-19 pandemic among health care workers and inpatients in China. Front Psychiatry. 2022 Oct 3;13:956068. doi: 10.3389/fpsyt.2022.956068.
16.Zhang Q, Ma X, Xing J, Shi H, Yang R, Jiao Y, Chen S, Wu S, Zhang S, Sun X. Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study. Front Endocrinol (Lausanne). 2021 May 13;12:657856. doi: 10.3389/fendo.2021.657856.
17.Liang L, Fang J, Han X, Zhai X, Song Y, Lu Y, Zhang Q, Ma R. Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei. Front Oncol. 2021 Oct 18;11:594763. doi: 10.3389/fonc.2021.594763.
18.Liang L, Han X, Zhou N, Xu H, Guo J, Zhang Q. Ultrasound for Preoperatively Predicting Pathology Grade, Complete Cytoreduction Possibility, and Survival Outcomes of Pseudomyxoma Peritonei. Front Oncol. 2021 Sep 15;11:690178. doi: 10.3389/fonc.2021.690178.
19.Zhang Q, Shi Y, Xin Y, Zhang S, Zeng N, Liu M, Wu S, Wei W, Li M, You H, Jia J, Kong Y, Grambow S. A multimodal international collaborative clinical research training program in China. Med Educ Online. 2019 Dec;24(1):1679944. doi: 10.1080/10872981.2019.1679944.
20. Zhang Q, Liu Z, Wu S, Duan W, Chen S, Ou X, You H, Kong Y, Jia J. Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis. Gastroenterol Res Pract. 2019 Jun 10;2019:8959103. doi: 10.1155/2019/8959103.
文件上传中...
